LATISSE (Allergan, Inc.)
Welcome to the PulseAid listing for the LATISSE drug offered from Allergan, Inc.. This Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | bimatoprost |
| SUBSTANCE NAME: | BIMATOPROST |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-01-26 |
| END MARKETING DATE: | 0000-00-00 |
LATISSE HUMAN PRESCRIPTION DRUG Details:
| Item Description | LATISSE from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.3(mg/mL) |
| START MARKETING DATE: | 2009-01-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-3616_c38a4d54-cf63-4c26-bbc4-756cb328f3c0 |
| PRODUCT NDC: | 0023-3616 |
| APPLICATION NUMBER: | NDA022369 |
Other BIMATOPROST Pharmaceutical Manufacturers / Labelers:
